secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quanterix Corp (QTRX)
CIK:        0001503274
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001628280-24-038023
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jeffrey Elliott appointed to Quanterix board; brings Exact Sciences experience
------------------------------------------------------------------------------

- Appointed effective August 19, 2024 as a Class I director with term expiring at 2027 annual meeting.
- Mr. Elliott served as CFO of Exact Sciences (2016-2024) and COO (2021-2023), scaling operations and overseeing acquisitions.
- Received initial equity award valued at $400,000: 60% stock options and 40% RSUs, vesting over three years.
- CEO Masoud Toloue cited Elliott's experience in scaling Alzheimer's disease testing infrastructure as valuable.
- No family relationships or material transactions requiring disclosure under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503274/000162828024038023/0001628280-24-038023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503274/000162828024038023/qtrx-20240819.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-038023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer